Column Group
Latest statistics and disclosures from Column Group's latest quarterly 13F-HR filing:
- Top 5 stock holdings are Surrozen, ORIC, RVMD, and represent 100.00% of Column Group's stock portfolio.
- Column Group has $88M in assets under management (AUM), dropping by -12.52%.
- Central Index Key (CIK): 0001833486
Tip: Access up to 7 years of quarterly data
Positions held by Column Group consolidated in one spreadsheet with up to 7 years of data
Download as csvPortfolio Holdings for Column Group
Column Group holds 3 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Surrozen | 56.5 | $50M | 1.9M | 25.95 |
|
|
| Oric Pharmaceuticals (ORIC) | 43.5 | $38M | 3.5M | 10.83 |
|
|
| Revolution Medicines (RVMD) | 0.0 | $8.6k | 46.00 | 187.28 |
|
Past Filings by Column Group
SEC 13F filings are viewable for Column Group going back to 2020
- Column Group 2026 Q2 filed Aug. 14, 2026
- Column Group 2026 Q1 filed May 18, 2026
- Column Group 2025 Q4 filed Feb. 13, 2026
- Column Group 2025 Q3 filed Nov. 14, 2025
- Column Group 2025 Q2 filed Aug. 15, 2025
- Column Group 2025 Q1 filed May 14, 2025
- Column Group 2024 Q4 filed Feb. 14, 2025
- Column Group 2024 Q3 filed Nov. 14, 2024
- Column Group 2024 Q2 filed Aug. 15, 2024
- Column Group 2024 Q1 filed May 15, 2024
- Column Group 2023 Q4 filed Feb. 9, 2024
- Column Group 2023 Q3 filed Nov. 13, 2023
- Column Group 2023 Q2 filed July 24, 2023
- Column Group 2023 Q1 filed May 15, 2023
- Column Group 2022 Q4 filed Feb. 13, 2023
- Column Group 2022 Q3 filed Nov. 14, 2022